Loading company…
Phylogix develops lectin-based drugs for tissue protection, oncology, and immunology.
Phylogix is a US-based biotechnology company developing lectin-based drugs for tissue protection, oncology, and immunology.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in